| Balance Sheets | 2025-10-31 | 2025-07-31 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 8,516 | 10,325 | ||
| Accounts receivable, net | 11,539 | 9,474 | ||
| Prepaid expenses and other current assets | 1,277 | 1,215 | ||
| Total current assets | 21,332 | 21,014 | ||
| Operating lease right-of-use assets, net | 4,348 | 4,771 | ||
| Property and equipment, net | 3,951 | 4,230 | ||
| Other long-term assets | 196 | 196 | ||
| Goodwill | 335 | 335 | ||
| Total assets | 30,162 | 30,546 | ||
| Accounts payable | 5,993 | 4,845 | ||
| Accrued liabilities | 2,188 | 1,801 | ||
| Current portion of operating lease liabilities | 1,525 | 1,506 | ||
| Other current liability | 97 | 116 | ||
| Deferred revenue | 12,338 | 14,430 | ||
| Total current liabilities | 22,141 | 22,698 | ||
| Non-current operating lease liabilities | 3,744 | 4,244 | ||
| Other non-current liabilities | 46 | 66 | ||
| Total liabilities | 25,931 | 27,008 | ||
| Common stock, .001 par value 200,000,000 shares authorized 14,006,659 and 13,897,503 shares issued and 13,886,326 and 13,777,170 outstanding as of july 31, 2025 and april 30, 2025, respectively | 14 | 14 | ||
| Treasury stock, at cost | 708 | 708 | ||
| Additional paid-in capital | 84,985 | 84,560 | ||
| Accumulated deficit | -80,121 | -80,358 | ||
| Total stockholders equity attributable to champions oncology, inc | 4,170 | 3,508 | ||
| Noncontrolling interest | 61 | 30 | ||
| Total stockholders' equity | 4,231 | 3,538 | ||
| Total liabilities and stockholders equity | 30,162 | 30,546 | ||
CHAMPIONS ONCOLOGY, INC. (CSBR)
CHAMPIONS ONCOLOGY, INC. (CSBR)